Healthcare · Pharmaceutical expenditure
Pharmaceutical expenditure in Botswana stands at 1 % GDP of GDP in 2026, a modest figure given the rising burden of non-communicable diseases. A significant portion of medicines is imported from South Africa and India, with the state's antiretroviral procurement program remaining a key cost driver. The country holds the 114th position among 197 nations.
Data for 2026 · unit: % GDP
Position
#114 / 197
Botswana world ranking
Country position on the scale from last to first place for this indicator.
BW
#114
#197#1
Trend
Change over time
Change in indicator over the available period.
1.00
1990
1.20
2000
1.40
2010
1.60
2020
1.00
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Botswana stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Botswana — how much?
Based on 2026 data — 1 % GDP. This is rank #114 out of 197 countries.
What is Botswana's rank by Pharmaceutical expenditure?
Botswana ranks #114 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Botswana?
Over the available period the indicator changed from 1 to 1 % GDP.